Literature DB >> 29703442

Recurrent Acute Decompensated Heart Failure Admissions for Patients With Reduced Versus Preserved Ejection Fraction (from the Atherosclerosis Risk in Communities Study).

Melissa C Caughey1, Carla A Sueta2, Sally C Stearns3, Amil M Shah4, Wayne D Rosamond5, Patricia P Chang2.   

Abstract

Hospitals are required to report all-cause 30-day readmissions for patients discharged with heart failure. Same-cause readmissions have received less attention but may differ for heart failure with reduced ejection fraction (HFrEF) versus heart failure with preserved ejection fraction (HFpEF). The ARIC study began abstracting medical records for cohort members hospitalized with acute decompensated heart failure (ADHF) in 2005. ADHF was validated by physician review, with HFrEF defined by ejection fraction <50%. Recurrent admissions for ADHF were analyzed within 30 days, 90 days, 6 months, and 1 year of the index hospitalization using repeat-measures Cox regression models. All recurrent ADHF admissions per patient were counted rather than the more typical analysis of only the first occurring readmission. From 2005 to 2014, 1,133 cohort members survived at least 1 hospitalization for ADHF and had ejection fraction recorded. Half were classified as HFpEF. Patients with HFpEF were more often women and had more co-morbidities. The overall ADHF readmission rate was greatest within 30 days of discharge but was higher for patients with HFrEF (115 vs 88 readmissions per 100 person-years). After adjustments for demographics, year of admission, and co-morbidities, there was a trend for higher ADHF readmissions with HFrEF, relative to HFpEF, at 30 days (hazard ratio [HR] 1.41, 95% confidence interval [CI] 0.92 to 2.18), 90 days (HR 1.39, 95% CI 1.05 to 1.85), 6 months (HR 1.47, 95% CI, 1.18 to 1.84), and 1 year (HR 1.42, 95% CI 1.18 to 1.70) of follow-up. In conclusion, patients with HFrEF have a greater burden of short- and long-term readmissions for recurrent ADHF.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 29703442      PMCID: PMC6842896          DOI: 10.1016/j.amjcard.2018.03.011

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  23 in total

1.  Racial and Ethnic Differences in Heart Failure Readmissions and Mortality in a Large Municipal Healthcare System.

Authors:  Matthew S Durstenfeld; Olugbenga Ogedegbe; Stuart D Katz; Hannah Park; Saul Blecker
Journal:  JACC Heart Fail       Date:  2016-07-06       Impact factor: 12.035

Review 2.  Angiotensin Receptor Neprilysin Inhibition in Heart Failure With Preserved Ejection Fraction: Rationale and Design of the PARAGON-HF Trial.

Authors:  Scott D Solomon; Adel R Rizkala; Jianjian Gong; Wenyan Wang; Inder S Anand; Junbo Ge; Carolyn S P Lam; Aldo P Maggioni; Felipe Martinez; Milton Packer; Marc A Pfeffer; Burkert Pieske; Margaret M Redfield; Jean L Rouleau; Dirk J Van Veldhuisen; Faiez Zannad; Michael R Zile; Akshay S Desai; Victor C Shi; Martin P Lefkowitz; John J V McMurray
Journal:  JACC Heart Fail       Date:  2017-06-26       Impact factor: 12.035

3.  Heart failure in the lifetime of Musca domestica (the common housefly).

Authors:  Marvin A Konstam
Journal:  JACC Heart Fail       Date:  2013-03-11       Impact factor: 12.035

4.  Lifetime analysis of hospitalizations and survival of patients newly admitted with heart failure.

Authors:  Soohun Chun; Jack V Tu; Harindra C Wijeysundera; Peter C Austin; Xuesong Wang; Daniel Levy; Douglas S Lee
Journal:  Circ Heart Fail       Date:  2012-05-02       Impact factor: 8.790

5.  Outcomes in patients with heart failure with preserved, borderline, and reduced ejection fraction in the Medicare population.

Authors:  Richard K Cheng; Margueritte Cox; Megan L Neely; Paul A Heidenreich; Deepak L Bhatt; Zubin J Eapen; Adrian F Hernandez; Javed Butler; Clyde W Yancy; Gregg C Fonarow
Journal:  Am Heart J       Date:  2014-07-22       Impact factor: 4.749

6.  Hospital readmissions reduction program.

Authors:  Colleen K McIlvennan; Zubin J Eapen; Larry A Allen
Journal:  Circulation       Date:  2015-05-19       Impact factor: 29.690

7.  Etiology of Heart Failure and Outcomes in Patients Hospitalized for Acute Decompensated Heart Failure With Preserved or Reduced Ejection Fraction.

Authors:  Katsuya Kajimoto; Yuichiro Minami; Naoki Sato; Hiroshi Kasanuki
Journal:  Am J Cardiol       Date:  2016-09-15       Impact factor: 2.778

8.  Rates and predictors of 30-day readmission among commercially insured and Medicaid-enrolled patients hospitalized with systolic heart failure.

Authors:  Larry A Allen; Karen E Smoyer Tomic; David M Smith; Kathleen L Wilson; Irene Agodoa
Journal:  Circ Heart Fail       Date:  2012-10-16       Impact factor: 8.790

9.  Characteristics and outcomes of hospitalized patients with heart failure and reduced vs preserved ejection fraction. Report from the Japanese Cardiac Registry of Heart Failure in Cardiology (JCARE-CARD).

Authors:  Miyuki Tsuchihashi-Makaya; Sanae Hamaguchi; Shintaro Kinugawa; Takashi Yokota; Daisuke Goto; Hisashi Yokoshiki; Norihiro Kato; Akira Takeshita; Hiroyuki Tsutsui
Journal:  Circ J       Date:  2009-07-31       Impact factor: 2.993

10.  Incidence and survival of hospitalized acute decompensated heart failure in four US communities (from the Atherosclerosis Risk in Communities Study).

Authors:  Patricia P Chang; Lloyd E Chambless; Eyal Shahar; Alain G Bertoni; Stuart D Russell; Hanyu Ni; Max He; Thomas H Mosley; Lynne E Wagenknecht; Tandaw E Samdarshi; Lisa M Wruck; Wayne D Rosamond
Journal:  Am J Cardiol       Date:  2013-11-09       Impact factor: 2.778

View more
  5 in total

Review 1.  Therapeutic Advances in the Management of Acute Decompensated Heart Failure.

Authors:  Elena-Laura Antohi; Andrew P Ambrosy; Sean P Collins; Ali Ahmed; Vlad Anton Iliescu; Gad Cotter; Peter S Pang; Javed Butler; Ovidiu Chioncel
Journal:  Am J Ther       Date:  2019 Mar/Apr       Impact factor: 2.688

2.  Burden and Outcomes of Heart Failure Hospitalizations in Adults With Chronic Kidney Disease.

Authors:  Nisha Bansal; Leila Zelnick; Zeenat Bhat; Mirela Dobre; Jiang He; James Lash; Bernard Jaar; Rupal Mehta; Dominic Raj; Hernan Rincon-Choles; Milda Saunders; Sarah Schrauben; Matthew Weir; Julie Wright; Alan S Go
Journal:  J Am Coll Cardiol       Date:  2019-06-04       Impact factor: 24.094

Review 3.  Inferior Vena Cava Edge Tracking Echocardiography: A Promising Tool with Applications in Multiple Clinical Settings.

Authors:  Stefano Albani; Luca Mesin; Silvestro Roatta; Antonio De Luca; Alberto Giannoni; Davide Stolfo; Lorenza Biava; Caterina Bonino; Laura Contu; Elisa Pelloni; Emilio Attena; Vincenzo Russo; Francesco Antonini-Canterin; Nicola Riccardo Pugliese; Guglielmo Gallone; Gaetano Maria De Ferrari; Gianfranco Sinagra; Paolo Scacciatella
Journal:  Diagnostics (Basel)       Date:  2022-02-07

4.  Prognostic Value of Shock Index, Modified Shock Index, and Age-Adjusted Derivatives in Prediction of In-Hospital Mortality in Patients with Acute Decompensated Heart Failure: Persian Registry of Cardiovascular Disease/ Heart Failure Study.

Authors:  Niloofar Bondariyan; Mehrbod Vakhshoori; Niyousha Sadeghpour; Davood Shafie
Journal:  Anatol J Cardiol       Date:  2022-03       Impact factor: 1.475

5.  Recurrent Admissions for Acute Decompensated Heart Failure Among Patients With and Without Peripheral Artery Disease: The ARIC Study.

Authors:  Zainali Chunawala; Patricia P Chang; Andrew P DeFilippis; Michael E Hall; Kunihiro Matsushita; Melissa C Caughey
Journal:  J Am Heart Assoc       Date:  2020-10-26       Impact factor: 5.501

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.